No increased risk of second cancer after radiotherapy in patients treated for rectal or endometrial cancer in the randomized TME, PORTEC-1, and PORTEC-2 trials

Journal of Clinical Oncology

Volumn 33, Issue 15, 2015, Pages 1640-1646

  Wiltink, Lisette M ^a   Nout, Remi A ^a   Fiocco, Marta ^a   Kranenbarg, Elma Meershoek Klein ^a   Jürgenliemk Schulz, Ina M ^b   Jobsen, Jan J ^c   Nagtegaal, Iris D ^d   Rutten, Harm J T ^e   Van De Velde, Cornelis J H ^a   Creutzberg, Carien L ^a   Marijnen, Corrie A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVOR; COHORT ANALYSIS; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; SECOND CANCER; STANDARDIZED INCIDENCE RATIO; ADVERSE EFFECTS; AGE; COMPLICATION; ENDOMETRIAL NEOPLASMS; META ANALYSIS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTAL NEOPLASMS; TIME;

AGE FACTORS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; PROBABILITY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; TIME FACTORS;

EID: 84933567330     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.6693     Document Type: Article

References (26)

1. Liu L, de Vries E, Louwman M, et al: Prevalence of multiple malignancies in the Netherlands in 2007. Int J Cancer 128:1659-1667, 2011
2. Berrington de Gonzalez A, Curtis RE, Kry SF, et al: Proportion of second cancers attributable to radiotherapy treatment in adults: A cohort study in the US SEER cancer registries. Lancet Oncol 12:353-360, 2011
3. Creutzberg CL, van Putten WL, Koper PC, et al: Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial - PORTEC Study Group: Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355:1404-1411, 2000
4. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646, 2001
5. Blake P, Swart AM, Orton J, et al: Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN. 5 randomised trials): Pooled trial results, systematic review, and meta-analysis. Lancet 373:137-146, 2009
6. Sauer R, Liersch T, Merkel S, et al: Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926-1933, 2012
7. Birgisson H, Påhlman L, Gunnarsson U, et al: Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23:6126-6131, 2005
8. Onsrud M, Cvancarova M, Hellebust TP, et al: Long-term outcomes after pelvic radiation for early-stage endometrial cancer. J Clin Oncol 31:3951-3956, 2013
9. Kendal WS, Nicholas G: A population-based analysis of second primary cancers after irradiation for rectal cancer. Am J Clin Oncol 30:333-339, 2007
10. Brown AP, Neeley ES, Werner T, et al: A population-based study of subsequent primary malignancies after endometrial cancer: Genetic, environmental, and treatment-related associations. Int J Radiat Oncol Biol Phys 78:127-135, 2010
11. Nout RA, Smit VT, Putter H, et al: Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial. Lancet 375:816-823, 2010
12. Marijnen CA, Kapiteijn E, van de Velde CJ, et al: Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: Report of a multicenter randomized trial. J Clin Oncol 20:817-825, 2002
13. Creutzberg CL, van Putten WL, Koper PC, et al: The morbidity of treatment for patients with stage I endometrial cancer: Results from a randomized trial. Int J Radiat Oncol Biol Phys 51:1246-1255, 2001
14. Nout RA, Putter H, Jürgenliemk-Schulz IM, et al: Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial. J Clin Oncol 27:3547-3556, 2009
15. Casparie M, Tiebosch AT, Burger G, et al: Pathology databanking and biobanking in the Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29:19-24, 2007
16. International rules for multiple primary cancers (ICD-0 third edition). Eur J Cancer Prev 14:307-308, 2005
17. Schemper M, Smith TL: A note on quantifying follow-up in studies of failure time. Control Clin Trials 17:343-346, 1996
18. Putter H, Fiocco M, Geskus RB: Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 26:2389-2430, 2007
19. Gray R: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
20. Nederlandse Kankerregistratie. http://www.cijfersoverkanker.nl/
21. de Wreede LC, Fiocco M, Putter H: The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models. Comput Methods Programs Biomed 99:261-274, 2010
22. de Wreede LC, Fiocco M, Putter H: Mstate: An R package for the analysis of competing risks and multi-state models. J Stat Softw 38, 2011
23. Keurentjes JC, Fiocco M, Schreurs BW, et al: Revision surgery is overestimated in hip replacement. Bone Joint Res 1:258-262, 2012
24. Kumar S, Shah JP, Bryant CS, et al: Second neoplasms in survivors of endometrial cancer: Impact of radiation therapy. Gynecol Oncol 113:233-239, 2009
25. Wood ME, Vogel V, Ng A, et al: Second malignant neoplasms: Assessment and strategies for risk reduction. J Clin Oncol 30:3734-3745, 2012
26. Renehan AG, Tyson M, Egger M, et al: Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578, 2008